Japanese Journal of Clinical Immunology
Online ISSN : 1349-7413
Print ISSN : 0911-4300
ISSN-L : 0911-4300
Review Articles
NF-κB as a therapeutic target of rheumatoid arthritis
Takashi OKAMOTOAtsushi TSUCHIYA
Author information
JOURNAL FREE ACCESS

2007 Volume 30 Issue 5 Pages 383-389

Details
Abstract
  Nuclear factor kappa B (NF-κB) is an inducible transcription factor that is activated through intracellular signal transduction pathways. Its target genes include those that are responsible for immuno-inflammatory responses, apoptosis inhibitors, growth promoting factors, virus-encoded proteins involved in viral replication, and self-regulatory proteins for NF-κB actions. Thus, it has been reported that NF-κB plays major roles in the pathogenesis of cancer, leukemia, autoimmune diseases such as rheumatoid arthritis, and AIDS. On the other hand, it has been revealed that some drugs that are effective in the treatment of rheumatoid arthritis have actually inhibitory activities of NF-κB actions. In this review, we have attempted to analyze various pathological steps of rheumatoid arthritis especially by depicting the steps that involve NF-κB. We also discuss possible therapeutic strategies with NF-κB as a major target.
Content from these authors
© 2007 The Japan Society for Clinical Immunology
Previous article Next article
feedback
Top